COVID-19 has strained population breast mammography screening programs that aim to
diagnose and treat breast cancers earlier. As the pandemic has affected countries …

Objective The ongoing COVID-19 pandemic has caused an indefinite delay to cancer
screening programs worldwide. This study aims to explore the impact on breast cancer …

Abstract Background In the United States, breast cancer is the most commonly diagnosed
cancer and second leading cause of cancer death in women. Early detection through …

Background Breast cancer screening utilization steeply dropped at the start of the
coronavirus disease 2019 (COVID‐19) pandemic. However, the effects on breast cancer …

Background: Breast cancer screening in Ontario, Canada, was deferred during the first wave
of the COVID-19 pandemic, and a prioritization framework to resume services according to …

Purpose In order to facilitate targeted outreach, we sought to identify patient populations with
a lower likelihood of returning for breast cancer screening after COVID-19-related imaging …

BACKGROUND To understand how health care delays may affect breast cancer detection,
the authors quantified changes in breast‐related preventive and diagnostic care during the …

The COVID-19 pandemic has disrupted preventive care, including cancer screening.
Studies from the United States and Europe have shown that cancer screening dropped …

Background Routine screening mammography at two-year intervals is widely recommended
for the prevention and early detection of breast cancer for women who are 50 years+. Racial …

Background Breast cancer care has been affected by the COVID-19 pandemic. This
systematic review aims to describe the observed pandemic-related changes in clinical and …